Genetic counseling for patients considering screening and diagnosis for chromosomal abnormalities.

Authors

Renée L. Chard, Maine Medical Center
Mary E Norton

Document Type

Article

Publication Date

6-2016

Institution/Department

Obstetrics & Gynecology

Journal Title

Clinics in laboratory medicine

MeSH Headings

Decision Making, Female, Genetic Counseling, Humans, Pregnancy, Prenatal Diagnosis, Risk Assessment

Abstract

With the introduction of cell-free DNA screening for fetal aneuploidy and chromosomal microarray for prenatal diagnostic testing, options for pregnant women have become increasingly complex. Discussions regarding options for prenatal testing for aneuploidy should occur prior to any testing and should include pertinent risks and benefits of each alternative test. There is no single screening or diagnostic test option that is the right choice for all patients; patient decisions should be based on each individual woman's values and preferences after a discussion of all options.

ISSN

1557-9832

Comments

Division of Maternal-Fetal Medicine, Maine Medical Partners Women's Health.

First Page

227

Last Page

236

Recommended Citation

Chard, Renée L. and Norton, Mary E, "Genetic counseling for patients considering screening and diagnosis for chromosomal abnormalities." (2016). MaineHealth Maine Medical Center. 412.
https://knowledgeconnection.mainehealth.org/mmc/412